Apogee Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
23 Aug 24 | SellUS$289,560 | Jane Pritchett Henderson | Individual | 6,000 | US$48.26 |
Insider Trading Volume
Insider Buying: APGE insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,182,460 | 1.66% |
Private Companies | 4,199,437 | 5.89% |
Hedge Funds | 4,762,558 | 6.67% |
VC/PE Firms | 15,236,642 | 21.4% |
Institutions | 45,975,942 | 64.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,236,642 | US$653.0m | 0% | 32.68% | |||
7,502,482 | US$321.6m | -0.04% | 0.02% | |||
4,814,400 | US$206.3m | 35.7% | 0.03% | |||
4,762,558 | US$204.1m | 0% | 17.57% | |||
2,975,917 | US$127.5m | 8.51% | no data | |||
2,712,096 | US$116.2m | 0% | 1.78% | |||
2,533,607 | US$108.6m | 19.6% | 0.69% | |||
2,259,073 | US$96.8m | 0% | no data | |||
2,127,042 | US$91.2m | 7.95% | no data | |||
2,015,007 | US$86.4m | -4.3% | 2.07% | |||
1,961,863 | US$84.1m | 0% | 1.12% | |||
1,940,364 | US$83.2m | 0% | no data | |||
1,643,226 | US$70.4m | -31.3% | 3.41% | |||
1,411,639 | US$60.5m | -9.59% | no data | |||
1,194,363 | US$51.2m | 5.48% | 0.02% | |||
1,000,000 | US$42.9m | 0% | 1.44% | |||
976,155 | US$41.8m | 30.8% | 0.39% | |||
851,989 | US$36.5m | -15.3% | 0.01% | |||
823,839 | US$35.3m | 11.2% | no data | |||
810,452 | US$34.7m | 85.8% | 0.09% | |||
766,763 | US$32.9m | -6.69% | no data | |||
758,081 | US$32.5m | -1.32% | no data | |||
701,817 | US$30.1m | 113% | 1.15% | |||
664,198 | US$28.5m | -20.6% | 5.3% | |||
627,089 | US$26.9m | 0% | 6.34% |